|
Originally published In Press as doi:10.1194/jlr.M300232-JLR200 on November 1, 2003
Journal of Lipid Research, Vol. 45, 347-355, February 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology
Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome
R. Kennedy Keller*,
Thomas P. Arnold and
Steven J. Fliesler1,
* Department of Biochemistry and Molecular Biology, University of South Florida College of Medicine, Tampa, FL
Department of Biology, Valencia Community College, Orlando, FL
Departments of Ophthalmology (St. Louis University Eye Institute) and Pharmacological and Physiological Science, St. Louis University School of Medicine, St. Louis, MO
1 To whom correspondence should be addressed. e-mail: fliesler{at}slu.edu
Smith-Lemli-Opitz syndrome (SLOS) is a recessive disease typified by 7-dehydrocholesterol (7DHC) accumulation and depletion of cholesterol. Because cholesterol is a primary component of detergent-resistant membrane domains ("rafts"), we examined the compatibility of 7DHC with raft formation. Liposomes containing bovine brain phosphatidylcholine, sphingomyelin, cerebrosides, and either cholesterol, 7DHC, or coprostanol (the latter being incompatible with raft formation) were prepared. 7DHC was indistinguishable from cholesterol in its ability to become incorporated into membrane rafts, as judged by physical and chemical criteria, whereas coprostanol did not form rafts. The in vivo compatibility of 7DHC with raft formation was evaluated in brains of rats treated with trans-1,4-bis(2-dichlorobenzylamino-ethyl)cyclohexane dihydrochloride (AY9944), which mimics the SLOS biochemical defect. 7DHC/cholesterol ratios in rafts and whole brains from AY9944-treated rats were similar, indicating comparable efficiency of 7DHC and cholesterol incorporation into brain rafts. In contrast, dolichol (a nonsterol isoprenoid incompatible with raft formation) was greatly depleted in brain rafts relative to whole brain.
Although brain raft fractions prepared from AY9944-treated and control rats yielded similar sterol-protein ratios, their gel electrophoresis profiles exhibited multiple differences, suggesting that altered raft sterol composition perturbs raft protein content. These results are discussed in the context of the SLOS phenotype, particularly with regard to the associated central nervous system defects.
Abbreviations: AY9944, trans-1,4-bis(2-dichlorobenzylaminoethyl) cyclohexane dihydrochloride; CB, galactocerebroside; 7DHC, 7-dehydrocholesterol; DOL, dolichol; HRP, horseradish peroxidase; MBS, MES-buffered saline; PC, phosphatidylcholine; SCAP, SREBP cleavage-activating protein; Shh, Sonic hedgehog; SLOS, Smith-Lemli-Opitz syndrome; SM, sphingomyelin; SREBP, sterol regulatory element binding protein; SSD, sterol-sensing domain Supplementary key words lipid domains proteomics brain rat

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X.-S. Jiang, C. A. Wassif, P. S. Backlund, L. Song, L. A. Holtzclaw, Z. Li, A. L. Yergey, and F. D. Porter
Activation of Rho GTPases in Smith-Lemli-Opitz syndrome: pathophysiological and clinical implications
Hum. Mol. Genet.,
April 1, 2010;
19(7):
1347 - 1357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Burke, P. L. Colvin, L. Myatt, G. A. Graf, F. Schroeder, and L. A. Woollett
Transport of maternal cholesterol to the fetus is affected by maternal plasma cholesterol concentrations in the Golden Syrian hamster
J. Lipid Res.,
June 1, 2009;
50(6):
1146 - 1155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Laloi, A.-M. Perret, L. Chatre, S. Melser, C. Cantrel, M.-N. Vaultier, A. Zachowski, K. Bathany, J.-M. Schmitter, M. Vallet, et al.
Insights into the Role of Specific Lipids in the Formation and Delivery of Lipid Microdomains to the Plasma Membrane of Plant Cells
Plant Physiology,
January 1, 2007;
143(1):
461 - 472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Pappu, W. E. Connor, L. S. Merkens, J. M. Jordan, J. A. Penfield, D. R. Illingworth, and R. D. Steiner
Increased nonsterol isoprenoids, dolichol and ubiquinone, in the Smith-Lemli-Opitz syndrome: effects of dietary cholesterol
J. Lipid Res.,
December 1, 2006;
47(12):
2789 - 2798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Jiang and G. E. Herman
Analysis of Nsdhl-deficient embryos reveals a role for Hedgehog signaling in early placental development
Hum. Mol. Genet.,
November 15, 2006;
15(22):
3293 - 3305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Megha, O. Bakht, and E. London
Cholesterol Precursors Stabilize Ordinary and Ceramide-rich Ordered Lipid Domains (Lipid Rafts) to Different Degrees: IMPLICATIONS FOR THE BLOCH HYPOTHESIS AND STEROL BIOSYNTHESIS DISORDERS
J. Biol. Chem.,
August 4, 2006;
281(31):
21903 - 21913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kovarova, C. A. Wassif, S. Odom, K. Liao, F. D. Porter, and J. Rivera
Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness
J. Exp. Med.,
May 15, 2006;
203(5):
1161 - 1171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Gondre-Lewis, H. I. Petrache, C. A. Wassif, D. Harries, A. Parsegian, F. D. Porter, and Y. P. Loh
Abnormal sterols in cholesterol-deficiency diseases cause secretory granule malformation and decreased membrane curvature.
J. Cell Sci.,
May 1, 2006;
119(Pt 9):
1876 - 1885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kim, M. C. Gondre-Lewis, I. Arnaoutova, and Y. P. Loh
Dense-Core Secretory Granule Biogenesis
Physiology,
April 1, 2006;
21(2):
124 - 133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. N. Tulenko, K. Boeze-Battaglia, R. P. Mason, G. S. Tint, R. D. Steiner, W. E. Connor, and E. F. Labelle
A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome
J. Lipid Res.,
January 1, 2006;
47(1):
134 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A Woollett
Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation
Am. J. Clinical Nutrition,
December 1, 2005;
82(6):
1155 - 1161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fernandez, M. Martin, D. Gomez-Coronado, and M. A. Lasuncion
Effects of distal cholesterol biosynthesis inhibitors on cell proliferation and cell cycle progression
J. Lipid Res.,
May 1, 2005;
46(5):
920 - 929.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Keller, M. Small, and S. J. Fliesler
Enzyme blockade: a nonradioactive method to determine the absolute rate of cholesterol synthesis in the brain
J. Lipid Res.,
October 1, 2004;
45(10):
1952 - 1957.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|